the FINESSE investigators. Facilitated PCI in patients with ST-elevation myocardial
infarction. N Engl J Med. 2008;358(21):2205-17.Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ et al. Analysis of
1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting
stent versus a standart stent in patients at high risk for coronary restenosis.
Circulation. 2004;109:634-40.
Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous
coronary interventions for ST-elevation myocardial infarction: quantitative review of
randomised trials. Lancet. 2006;67(9510):579-88.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Lancet. 2003;361:13-20.
Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH Jr, Coleman PS. The “final” 5-
year follow-up from the ENDEAVOR IV Trial comparing a zotarolimus-eluting stent
with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013;6(4):325-33.
Levine GM, Bates ER, Blankenship JC, Bailey SR, Bitti JA, Cercek B. 2011
ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the
American College of Cardiology Foundation/American Heart Association Task Force
on Practice Guidelines and the Society for Cardiovascular Angiography and
Interventions. Circulation. 2011;124(23):e579-e651.
Mattos LA, Lemos Neto PA, Rassi A Jr, Marin Neto JA. Diretrizes da Sociedade
Brasileira de Cardiologia – Intervenção Coronária Percutânea e Métodos Adjuntos
Diagnósticos em Cardiologia Intervencionista (II Edição – 2008). Arq Bras.
2008;91(6, supl 1):1-58.
Popma JJ, Bhatt DL. Intervenções coronárias percutâneas. In: Braunwald E, Zipes DP,
Libby P. Tratado de doenças cardiovasculares. 9. ed. Rio de Janeiro: Elsevie; 2013.
Capítulo 58, p. 1297-1315.
Serruys PW, Morice MC, Kapptein AP, Colombo A, Holmes DR, Mack MJ et al. for the
SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery
bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):p.
961-72.
Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A et al. Long-term
clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable
polymer sirolimus-eluting stents in patients with coronary artery disease
(LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet.
2011;378(9807):1940-8.
Stone GW, Ellis SG, Cox DA, Hermiller JB, O’Shaughnessi C, Popma JJ et al. A